ArticleSpine deformity2026
A changing early onset scoliosis phenotype in spinal muscular atrophy: nusinersen treatment is associated with younger age, increased curve magnitude, and kyphosis at the time of index surgery.
Article in Spine deformity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNusinersen provides functional benefits to Spinal Muscular Atrophy (SMA) patients but does not affect the prevalence or progression of scoliosis. This study aims to characterize perioperative curve characteristics and patient demographics among patients with SMA undergoing surgical treatment for early onset scoliosis (EOS) in a period spanning the introduction of nusinersen, a disease-modifying therapy.
methodsThis retrospective cohort study utilized a multicenter international pediatric spinal deformity database. Patients with SMA undergoing initial surgical treatment for scoliosis between 1996 and 2023 were included. Patients were stratified by exposure to nusinersen preoperatively. Preoperative clinical, radiographic characteristics, and first erect postoperative radiographic parameters were compared between groups.
resultsA total of 210 patients were included, 37 with preoperative nusinersen exposure and 173 controls. Patients in the nusinersen group were younger at the time of intervention (6.5 vs. 7.6 years, p = 0.006) and had more spinal levels instrumented post-operatively (10.5 vs. 9.5, p = 0.033). Preoperative kyphosis (78° vs. 67°, p = 0.027) and major curve magnitude (83° vs. 75°, p = 0.030) were higher in the nusinersen group. Postoperative kyphosis was also greater in this group (48° vs 42°, p = 0.042). There was no difference in postoperative major curve magnitude or percent correction. The nusinersen group was more commonly treated with magnetically controlled growing rods. A contemporaneous subgroup analysis (post-2017) showed that patients treated with nusinersen were younger at the time of surgery, although no significant differences in preoperative curve characteristics were noted.
conclusionNusinersen exposure was associated with younger age at surgery, greater curve magnitude, and increased kyphosis. These findings highlight potential changes in the phenotype of surgical candidates with EOS and SMA among patients treated with Nusinersen.
Indexed as
Identifiers
42754816What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.